Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-09-06

Clinical Trial Update: Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. [NA]

View source ↗

Summary

A trial investigating ciclopirox as a chemopreventive/antineoplastic agent for vulvar cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclopirox (ciclopirox)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Vulvar Cancer | NA | Status: WITHDRAWN